Emsella for Reducing tSUI After HOLEP

Starting soon · Not applicable

Conditions studied: Benign Prostatic Hyperplasia, Enlarged Prostate With Lower Urinary Tract Symptoms, Enlarged Prostate (BPH)

In brief

This study aims to investigate the effectiveness of the Emsella chair treatments at different timepoints. Before and after the holmium laser enucleation of the prostate (HoLEP).

Key facts

Study ID

NCT07580404

Run by

Northwestern University

People needed

30

Starts

2026-06-01

Expected to finish

2028-06-01

Last updated by the study team

2026-05-12

Who can join

Age: 50 and older, up to 80. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• Prostate sizing 80-150g
• Ability to independently transfer and tolerate all 30min Emsella treatments (e.g. not wheelchair bound, no mobility issues)
• Baseline M-ISI scores <4
• Same-day catheter removal and discharge
• Able to read, understand, and complete surveys and questionnaires

You may not qualify if…

• Catheter dependence
• Previous BPH procedure
• Previous pelvic surgeries
• Pre-existing pelvic floor dysfunction
• Neurogenic bladder
• Overactive bladder - e.g. prescribed and taking any oxybutynin or mirabegron
• Preoperative pad-use for incontinence

Where it is running

• Northwestern University — Chicago, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.